Abstract
The asymptomatic oropharyngeal colonization rate by Streptococcus pyogenes was 10.7% in children (901 among 8,405 children 0–16 years old) and 3.3% in adults (37 among 1,126 households of children) in the Lisbon area during 2000–2006. Macrolide-resistant S. pyogenes from children (n = 149) was variable with time: 9.8–10.7% in 2000–2002, 28.1% in 2003, 19.6–2.7% in 2004–2005 and 14.6% in 2006. Eight lineages (97.3% of isolates) were identified based on at least 80% similarity of PFGE patterns, T types, emm types and multilocus sequence types (ST). The elevated frequency of macrolide resistance was associated with M phenotype lineages I (emm12/ST36) and V (emm4, emm75/ST39 and a novel emmstMrp6 type) and with one cMLSB lineage IV (emm28/ST52) known to be associated with upper respiratory tract and invasive infections. Significant associations (p < 0.05) between emm type/virulence genotype were found, such as emm1/speA + ssa -, emm4/ssa + prtF1 +, emm12/speA - ssa -. The high prevalence (>20%) of speC, prtF1 or ssa was probably caused either by clonal dissemination (speC), or to horizontal gene transfer events (prtF1 and ssa). This report contributes to a better understanding of the molecular epidemiology and evolution of macrolide-resistant S. pyogenes causing symptom-free oropharyngeal colonization. These colonizing strains carry macrolide resistance and virulence genes capable of being transferred to other bacterial species sharing the same niche.
Similar content being viewed by others
References
Cunningham MW (2000) Pathogenesis of Group A streptococcal infections. Clin Microbiol Rev 13:470–511
Pichichero ME, Marsocci SM, Murphy AML, Hoeger W, Green JL, Sorrento A (1999) Incidence of streptococcal carriers in private pediatric practice. Arch Pediatr Adolesc Med 153:624–628
Fazeli MR, Ghaemi E, Tabarraei A, Kaplan EL, Johnson DR, Vakili MA, Khodabakhshi B (2003) Group A streptococcal serotypes isolated from healthy schoolchildren in Iran. Eur J Clin Microbiol Infect Dis 22:475–478
Aguero J, Ortega-Mendi M, Eliecer MC, de Aledo AG, Calvo J, Vilória L, Mellado P, Pelayo T, Fernandez-Rodriguez A, Martinez-Martinez L (2008) Outbreak of invasive Group A streptococcal disease among children attending a day-care center. Pediatr Infect Dis J 27:602–604
Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH (2002) Practice guidelines for the diagnosis and management of Group A streptococcal pharyngitis. Clin Infect Dis 35:113–125
Felmingham D, Farrell DJ, Reinert RR, Morrissey I (2004) Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999–2000). J Infect 48:39–55
Creti R, Gherardi G, Imperi M, von Hunolstein C, Baldassarri L, Pataracchia M, Alfarone G, Cardona F, Dicuonzo G, Orefici G (2005) Association of Group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation. J Med Microbiol 54:913–917
Pires R, Rolo D, Gama-Norton L, Morais A, Lito L, Salgado MJ, Johansson C, Möllerberg G, Henriques-Normark B, Gonçalo-Marques J, Santos-Sanches I (2005) Group A streptococci from carriage and disease in Portugal: evolution of antimicrobial resistance and T antigenic types during 2000–2002. Microb Drug Resist 11:360–370
Chang H, Shen X, Fu Z, Liu L, Shen Y, Liu X, Yu S, Yao K, Zhao C, Yang Y (2010) Antibiotic resistance and molecular analysis of Streptococcus pyogenes isolated from healthy schoolchildren in China. Scand J Infect Dis 42:84–89
Sutcliffe J, Tait-Kamradt A, Wondrack L (1996) Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 40:1817–1824
Seppälä H, Skurnik M, Soini H, Roberts MC, Huovinen P (1998) A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 42:257–262
McCormick JK, Schlievert PM (2000) Toxins and superantigens of Group A streptococcci. In: Fischetti VA et al (eds) Gram-positive pathogens. American Society for Microbiology Press, Washington DC, USA, pp 43–52
Talay SR, Valentin-Weigand P, Jerlström PG, Timmis KN, Chhatwal GS (1992) Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect Immun 60:3837–3844
Pires R, Rolo D, Mato R, de Almeida JF, Johansson C, Henriques-Normark B, Morais A, Brito-Avô A, Gonçalo-Marques J, Santos-Sanches I (2009) Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes. FEMS Microbiol Lett 296:235–240
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, sixteenth informational supplement. CLSI document M100-S16. Wayne, PA: CLSI, 2006.
Seppälä H, Nissinen A, Yu Q, Huovinen P (1993) Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32:885–891
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strains typing. J Clin Microbiol 33:2233–2239
Klugman KP, Capper T, Widdowson CA, Koornhof HJ, Moser W (1998) Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J Antimicrob Chemother 42:729–734
Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J (2004) Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist 10:31–36
Iimura T, Kashiwagi Y, Endo M, Amano Y (2006) Prevalence and persistence of certain serologic types of Streptococcus pyogenes in metropolitan Tokyo. J Infect Chemother 12:53–62
De Melo MCN, Figueiredo AMS, Ferreira-Carvalho BT (2003) Antimicrobial susceptibility patterns and genomic diversity in strains of Streptococcus pyogenes isolated in 1978–1997 in different Brazilian cities. J Med Microbiol 52:251–258
Silva-Costa C, Pinto FR, Ramirez M, Melo-Cristino J, Portuguese Surveillance Group for the Study of Respiratory Pathogens (2008) Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Clin Microbiol Infect 14:1152–1159
Baldassarri L, Creti R, Imperi M, Recchia S, Pataracchia BM, Alfarone G, Orefici G (2007) Detection of genes encoding internalization-associated proteins in Streptococcus pyogenes isolates from patients with invasive diseases and asymptomatic carriers. J Clin Microbiol 45:1284–1287
Creti R, Imperi M, Baldassarri L, Pataracchia M, Recchia S, Alfarone G, Orefici G (2007) emm types, virulence factors and antibiotic resistante of invasive S. pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol 45:2249–2256
Friães A, Ramirez M, Melo-Cristino J, the Portuguese Group for the Study of Streptococcal Infections (2007) A non-outbreak surveillance of Group A streptococci causing invasive disease in Portugal identified internationally disseminated clones among a genetically heterogeneous population. J Clin Microbiol 45:2044–2047
Traverso F, Sparo M, Rubio V, Sáez Nieto JÁ (2010) Molecular characterization of Streptococcus pyogenes from invasive disease and streptococcal toxic shock syndrome episodes. Rev Argent Microbiol 42:41–45
Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M (2004) Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the ketolide telithromycin: results from the PROTEKT surveillance study (1999–2000). Chemotherapy 50:143–151
McGregor KF, Spratt BG (2005) Identity and prevalence of multilocus sequence typing-defined clones of Group A streptococci within a hospital setting. J Clin Microbiol 43:1963–1967
Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J, Martín R, Liñares J (2010) Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993–2008). J Antimicrob Chemother 65:634–643
Silva-Costa C, Ramirez M, Melo-Cristino J (2006) Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal. Clin Microbiol Infect 12:513–518
Mihaila-Amrouche L, Bouvet A, Loubinoux J (2004) Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. J Clin Microbiol 42:3844–3846
Littauer L, Caugant DA, Sangvik M, Høiby EA, Sundsfjord A, Simonsen GS, the Norwegian Macrolide Study Group (2006) Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother 50:1896–1899
Malhotra-Kumar S, Wang S, Lammens C, Chapelle S, Goossens H (2003) Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium. J Clin Microbiol 41:5282–5284
Grivea IN, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR (2006) Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob Agents Chemother 50:256–261
Molinari G, Talay SR, Valentin-Weigand P, Rohde M, Chhatwal GS (1997) The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of Group A streptococci by epithelial cells. Infect Immun 65:1357–1363
Coenen S, Ferech M, Malhotra-Kumar S, Hendrickx E, Suetens C, Goossens H (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 58:418–422
Malhotra-Kumar S, Lammens C, Coenen S, Herck KV, Goosens H (2007) Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 369:482–490
Acknowledgements
This work was supported by Projects ref. POCTI/ESP/41971/2001 and POCTI/ESP/48407/2002 from Fundação para a Ciência e a Tecnologia (FCT), Portugal, and FEDER, awarded to Ilda Santos-Sanches, and Project ref. 212/1999 from Ministério da Saúde, Portugal, awarded to José Gonçalo-Marques. Dora Rolo was recipient of Grant BI 48407/2002 (2004–2006) and Renato Pires was recipient of Grants BI 41971/2001 (2002–2004) and SFRH/BD/32374/2006 (2007–2010), all from FCT, Portugal. None of the authors has any potential conflicts of interest.
The authors would like to thank Patrícia Broeiro, Paula Correia, and Carla Pereira (Centro de Saúde do Lumiar, Lisboa); Luísa Romeiro, Fátima Vaz, Teresa Ramos, Clotilde Gameiro, Filomena Andrade, Ana Lopes, Joana Queiroga, and Inês Dias (Centro de Saúde de Oeiras, Oeiras) for their participation in the collection of isolates from carriers. The authors are also grateful to Gian Maria Rossolini and Stefania Cresti (University of Siena, Italy); Birgitta Henriques-Normark (Swedish Institute for Infectious Disease Control, Solna, Sweden); Malak Kotb (University of Tennessee, Memphis, USA), and Gursharan Singh Chhatwal (German National Research Centre for Biotechnology, Braunschweig, Germany) for providing the control isolates for PCR assays. We also thank Lélia Chambel, Rogério Tenreiro, Sandra Chaves, and Tânia Tenreiro, from the Instituto de Ciência Aplicada e Tecnologia (ICAT) for guidance with BioNumerics software. We also thank Gabriela Ribeiro (Grant BIC 41971/2001 [2001–2002] from FCT, Portugal), Leonor Gama-Norton, Rita Cabral, Ana Margarida Sousa, Cláudia Marques, Sónia Custódio, Alexandra Nunes, Luís Sobreira, Sónia Cândido, Débora Tavares, Inês Faustino, and Maria João Santos for partial characterization of the isolates, and to Ingrid Andersson for excellent technical assistance. We acknowledge the use of the Streptococcus pyogenes MLST database, which is located at Imperial College London and is funded by the Wellcome Trust.
This study was presented in part, as a poster presentation (Abstr. P755) at the 25th International Congress of Chemotherapy (ICC)/17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID; Munich, Germany, 31 March 31 to 3 April 2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pires, R., Rolo, D., Morais, A. et al. Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000–2006 in the Lisbon area. Eur J Clin Microbiol Infect Dis 31, 849–857 (2012). https://doi.org/10.1007/s10096-011-1384-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-011-1384-x